Today, we’re excited to welcome Allan Bradley to Gravity Encounters. As the Founder and CEO of T-Therapeutics, Allan has had a profound impact on the fields of genomics, monoclonal antibody discovery, and biotech entrepreneurship.

Previously, as the Director of the Wellcome Trust Sanger Institute, Allan played a pivotal role in transforming its genome-sequencing infrastructure into a world-class research centre. His academic research laid the foundation for Kymab Ltd, a humanised antibody discovery company that led to the development of novel therapeutic antibodies, some of which have demonstrated clinical benefits.

Beyond Kymab, Allan co-founded PetMedix, applying cutting-edge antibody technologies to animal health. Earlier in his career, he spun out Lexicon Genetics while at Baylor College of Medicine, which went on to a $1 billion NASDAQ debut within just five years. A Fellow of the Royal Society and an expert in mouse genetics, Allan has significantly shaped the biotech landscape.

Today, we’ll explore Allan’s journey, from academia to building billion-dollar companies, and the scientific and entrepreneurial insights he’s gained along the way.

Hosts: Emily James and Jan Venne

Warning: This podcast contains strong language.

Today, we’re excited to welcome Alex Teng to Gravity Encounters. As a Partner at Fifty Years, Alex has forged a career at the intersection of science, technology, and entrepreneurship, backing founders who are leveraging cutting-edge innovation to tackle humanity's greatest challenges.

From his academic foundations at UC Berkeley and Caltech to pioneering environmental research with NASA, his career spans diverse ventures, including building net-zero emission vehicles at Divergent 3D, developing in-nose air filters at AVA, and designing advanced scientific instrumentation to probe the complexities of atmospheric chemistry.

With a unique blend of scientific expertise and entrepreneurial drive, Alex has consistently demonstrated the power of innovation to create meaningful change. Today, we’ll delve into the experiences, milestones, and insights that have shaped his remarkable path.

Hosts: Emily James and Jan Venne

Today, we’re excited to welcome Michael Anstey to Gravity Encounters, Partner at Cambridge Innovation Capital. With a career that bridges science, entrepreneurship, and venture capital, Mike has been a driving force behind some of biotech’s most exciting innovations. From earning a DPhil in neurobiology at Oxford to co-founding a company whilst working at BCG, and guiding startups like Bicycle Therapeutics, his journey is a testament to the power of bold ideas and calculated risks. As a leader at Cambridge Innovation Capital and co-founder of Innovate Cambridge, Mike is shaping the future of biotech and the innovation ecosystem. Today, we’ll dive into the moments, challenges, and insights that have defined his extraordinary path.

Hosts: Emily James and Jan Venne